Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Why Pharma Must Change Its Model

A difficult feat to accomplish in business is to make dramatic change in the midst of current success. History is littered with companies that were once on top of the world and today are non-existent or merely footnotes because they were unable to make sustainable changes when times were good and yet change was required. […]

Read More »

FDA warns of security flaw in Hospira infusion pumps

The U.S. Food and Drug Administration on Friday advised hospitals not to use Hospira Inc’s Symbiq infusion system, saying a security vulnerability could allow cyber attackers to take remote control of the system. The agency issued the advisory some 10 days after the U.S. Department of Homeland Security warned of the vulnerability in the pump, […]

Read More »

More research links sedentary time to diabetes

People who are inactive for hours on end each day may be more likely to develop diabetes than people who spend more time moving around, a study confirms. Researchers gave accelerometers to about 2,000 people to track their movements during waking hours for one week. Five years later, compared to people who were sedentary for […]

Read More »

FDA says investigating latest cyclosporiasis outbreak

The U.S. Food and Drug Administration said it is investigating the latest outbreak of cyclosporiasis in the United States. The Centers for Disease Control and Prevention (CDC) has been notified of about 358 confirmed cases of the infection until Thursday, the FDA said in a statement on its website. (1.usa.gov/1SQUB6Z) The agency said it has […]

Read More »

For seniors, sexual activity is linked to higher quality of life

Older adults who value sexual activity and engage in it have better social lives and psychological well-being, according to a small study in Scotland. Older adults said “they miss and want to engage in sexual behaviors, whether that be a kiss to intercourse,” said study coauthor Taylor-Jane Flynn in an email. “For many, these behaviors […]

Read More »

Vaccine success holds hope for end to deadly scourge of Ebola

The world is on the verge of being able to protect humans against Ebola, the World Health Organization said on Friday, as a trial in Guinea found a vaccine to have been 100 percent effective. Initial results from the trial, which tested Merck (MRK.N) and NewLink Genetics’ (NLNK.O) VSV-ZEBOV vaccine on some 4,000 people who […]

Read More »

Exercise during teens reaps long-term benefits for women, study shows

Playing team sports and exercising during adolescence can have long-lasting benefits for women and may even reduce their risk of dying from cancer and other causes later in life, a new study showed on Friday. Researchers who analyzed how often women exercised while in their teens found that being active for just 1.3 hours a […]

Read More »

WHO’s Chan says initial results from Ebola vaccine trial promising’

Initial results from an Ebola vaccine trial in Guinea are “exciting” and “promising” and suggest the shot could help bring an end to West Africa’s epidemic, World Health Organization director general Margaret Chan said on Friday. “If proven effective, this is going to be a game changer, and it will change the management of the […]

Read More »

AstraZeneca Halts Three Clinical Trial Programs, Reports Six Quarters of Top-line Growth

At the very end of its 2015 half-year financial report, on page 49, AstraZeneca PLC (AZN) noted the termination of three projects between April 1 and June 30. They were a program for selumetinib for uveal melanoma, tenapanor for ESRD-pi/CKD with T2DM and Nexium for refractory reflux esophagitis. The selumetinib and tenapanor programs were halted […]

Read More »

FDA Approves Bayer’s Finacea (azelaic acid) Foam, 15% for the Topical Treatment of the Inflammatory Papules and Pustules of Mild to Moderate Rosacea

WHIPPANY, N.J., July 31, 2015 /PRNewswire/ — Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has approved Finacea® (azelaic acid) Foam, 15% for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. The approval is based on results from two pivotal clinical trials examining the efficacy and […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2018 Focus: Top 50 Pharma, Company of the Year and more!

Subscribe

Ad Right Bottom